Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon Meledathu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Drugs in Dermatology : JDD|November 9, 2023
Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature ReviewShannon Meledathu, Michael Gordon, Mason Thornton, et al.
The Journal of Allergy and Clinical Immunology|January 24, 2025
Update on atopic dermatitisShannon Meledathu, Malini P Naidu, Patrick M Brunner
JAAD Case Reports|December 17, 2024
Bruton's tyrosine kinase inhibitor associated localized extremity edema and erythemaShannon Meledathu, Paul Chu, Tatyana Feldman, et al.
JMIR Dermatology|September 12, 2025
Omission of Risk in Vitamin A-Related Dermatologic Instagram Posts: A Growing Concern in an Unregulated Digital LandscapeRobert John Vanaria, Michael Povelaitis, Riya Khokhal, et al.
The Journal of Allergy and Clinical Immunology|December 18, 2024
Single-cell RNA sequencing of chronic idiopathic erythroderma defines disease-specific markersSumanth Chennareddy, Katharina Rindler, Shannon Meledathu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 6, 2025
scRNA-Seq reveals anti-lymphoma immune responses in mogamulizumab-associated skin eruptionsShannon Meledathu, Agata Kurowski, Malini P Naidu, et al.
Blood Advances|May 5, 2026
LYP vs. advanced-stage CTCLs: Single-cell profiling reveals markers of self-limited vs. aggressive disease behaviorShannon Meledathu, Sumanth Chennareddy, Malini P Naidu, et al.
The New England Journal of Medicine|August 20, 2025
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell TherapyAdolfo Aleman, Oliver Van Oekelen, David T Melnekoff, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Drugs in Dermatology : JDD|November 9, 2023
Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature ReviewShannon Meledathu, Michael Gordon, Mason Thornton, et al.
The Journal of Allergy and Clinical Immunology|January 24, 2025
Update on atopic dermatitisShannon Meledathu, Malini P Naidu, Patrick M Brunner
JAAD Case Reports|December 17, 2024
Bruton's tyrosine kinase inhibitor associated localized extremity edema and erythemaShannon Meledathu, Paul Chu, Tatyana Feldman, et al.
JMIR Dermatology|September 12, 2025
Omission of Risk in Vitamin A-Related Dermatologic Instagram Posts: A Growing Concern in an Unregulated Digital LandscapeRobert John Vanaria, Michael Povelaitis, Riya Khokhal, et al.
The Journal of Allergy and Clinical Immunology|December 18, 2024
Single-cell RNA sequencing of chronic idiopathic erythroderma defines disease-specific markersSumanth Chennareddy, Katharina Rindler, Shannon Meledathu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 6, 2025
scRNA-Seq reveals anti-lymphoma immune responses in mogamulizumab-associated skin eruptionsShannon Meledathu, Agata Kurowski, Malini P Naidu, et al.
Blood Advances|May 5, 2026
LYP vs. advanced-stage CTCLs: Single-cell profiling reveals markers of self-limited vs. aggressive disease behaviorShannon Meledathu, Sumanth Chennareddy, Malini P Naidu, et al.
The New England Journal of Medicine|August 20, 2025
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell TherapyAdolfo Aleman, Oliver Van Oekelen, David T Melnekoff, et al.
Pageof 1